Project Grant RF1AG079307
Award Date
8/1/22
Completion Date
7/31/25
Dollars Obligated
$3.9M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Irwindale, CA 91010, USA
Similar Awards
This three-year, $3.24 million project grant from the National Institutes of Health National Institute on Aging will fund research into the role of clusterin in oligodendrocyte lineage and myelination in Alzheimer's disease. Specifically, the University of Virginia researchers will pursue three aims: 1) determine the mechanisms of clusterin expression and its inhibition of oligodendrocyte progenitor cell differentiation; 2) assess the impact of pathological clusterin expression on myelination,...
This $1,559,999 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a comprehensive study to elucidate how the AANCR enhancer RNA regulates APOE gene expression and how APOE function affects cellular responses to stress in the central nervous system. The research aims to advance understanding of APOE4, a major genetic risk factor for Alzheimer's disease, in order to inform the development of targeted interventions. The project will leverage...
The National Institutes of Health's National Institute on Aging awarded a $7,432,562 project grant to the Regents of the University of California, San Francisco on September 15, 2022 under the Aging Research program (CFDA 93.866). The grant will support research to elucidate the roles of Alzheimer's disease risk genes and variants in gene expression and AD-related phenotypes through 2025. Specifically, the University of California, San Francisco will use CRISPR and single-cell RNA sequencing...
This $431,750 Project Grant was awarded by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The grant's objective is to investigate the interaction between biological sex and APOE genotype in modulating the risk of Alzheimer's disease (AD). The research will utilize isogenic human induced pluripotent stem cell (hiPSC) lines to dissect how APOE genotypes and sex chromosomes influence key pathological mechanisms of AD, including amyloid-beta...
This $5,274,018 project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866). The J. David Gladstone Institutes will study the susceptibility and resistance to the detrimental effects of the Apolipoprotein E4 (APOE4) genetic risk factor for Alzheimer's disease. The research aims to characterize neurophysiological, behavioral, and neuropathological differences between new APOE4 mouse lines...
This National Institute on Aging (NIA) Project Grant under Federal Assistance Catalog 93.866 "Aging Research" provides $235,500 to Arizona State University (ASU) to investigate how a specific variant of the APOE gene (APOE R145C) influences the risk and progression of Alzheimer's disease in the African American population. The 2-year project will use human induced pluripotent stem cells (hiPSCs) to model the effects of this genetic variant on Alzheimer's-related cellular phenotypes,...
This $125,896 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support the genetic and single-cell multi-omic characterization of Alzheimer's disease (AD) risk and resilience pathways. The Washington University in St. Louis will utilize state-of-the-art single-nuclei multi-omic functional genomic analyses of healthy and AD human brain tissue, as well as transgenic AD mouse models, to perform deep molecular profiling across genetic,...
This Cooperative Agreement award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) provides $810,698 to support research aimed at identifying new genetic risk and protective factors for Alzheimer's disease (AD) and investigating the underlying biological mechanisms. The primary awardee, Trustees of Boston University, will leverage large-scale genome-wide association studies (GWAS) and whole genome/exome sequencing datasets to discover novel AD-associated...
This Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, provides $4,563,558 under the Aging Research program (CFDA 93.866) to the Jackson Laboratory from September 15, 2022 to August 31, 2025. The funding supports research to model the genetic interaction between the Klotho and ApoE alleles in Alzheimer's disease. Specifically, the awardee will characterize new mouse models harboring relevant human variants in both Klotho and ApoE to...
This federal Project Grant award, with an ID of R01AG090773, is funded by the National Institute on Aging under the Aging Research Program (CFDA 93.866). The University of California, Los Angeles (UCLA) is the prime awardee and will receive $751,442 over the period from December 15, 2024 to November 30, 2029. The goal of this project is to optimize and evaluate a brain-penetrant CRISPR-based gene editing approach to convert the Alzheimer's disease genetic risk factor APOE4 to the benign APOE3...